Aligos Therapeutics Inc Financial Flexibility Index
Aligos Therapeutics Inc financial flexibility index. Aligos Therapeutics Inc (ALGS) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-23.06 Million (operating CF $-23.13 Million minus capex $69.00K) represents -1% of total liabilities ($32.77 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Aligos Therapeutics Inc (2018–2025)
Financial flexibility index of Aligos Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Aligos Therapeutics Inc across 8 annual periods. Check Aligos Therapeutics Inc (ALGS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Aligos Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Aligos Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Aligos Therapeutics Inc. For the full cash flow conversion analysis, see ALGS cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.35x | $-82.07 Million | $-82.50 Million | $34.99 Million | ▼ -188.2% |
| 2024 | -0.81x | $-80.61 Million | $-80.74 Million | $99.07 Million | ▲ +38.8% |
| 2023 | -1.33x | $-78.98 Million | $-79.00 Million | $59.45 Million | ▲ +27.5% |
| 2022 | -1.83x | $-78.45 Million | $-79.39 Million | $42.79 Million | ▲ +19.1% |
| 2021 | -2.27x | $-114.77 Million | $-115.66 Million | $50.64 Million | ▼ -42.1% |
| 2020 | -1.60x | $-72.20 Million | $-74.26 Million | $45.26 Million | ▼ -666.7% |
| 2019 | -0.21x | $-43.98 Million | $-46.77 Million | $211.41 Million | ▼ -615.3% |
| 2018 | -0.03x | $-3.53 Million | $-6.05 Million | $121.48 Million | — |